Bela-Andre Popper

Rituximab enhances radiation-triggered apoptosis in non-Hodgkin's lymphoma cells via caspase-dependent and - independent mechanisms.

S. Skvortsov, H. Zwierzina, A. Gunkel, 2006, Journal of radiation research.

Feasibility and Toxicity of Concomitant Radio/Immunotherapy with MabThera (Rituximab®) for Patients with Non-Hodkin's Lymphoma

M. Steurer, P. Lukas, A. Haidenberger, 2011, Strahlentherapie und Onkologie.

Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells.

S. Skvortsov, H. Zwierzina, P. Lukas, 2005, Journal of radiation research.

Intracellular signaling pathways regulating radioresistance of human prostate carcinoma cells

Bernhard Schiestl, S. Skvortsov, L. Huber, 2008, Proteomics.

Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse.

O. Riesterer, S. Skvortsov, L. Huber, 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.